DESK REVIEWS | 04.06.05.01. Who developed the guidelines, and when were they developed?

DESK REVIEW | 04.06.05.01. Who developed the guidelines, and when were they developed?

The “Clinical Protocol of Therapeutic Guidelines about Alzheimer’s Disease” was developed in 2017 by the Ministry of Health (Brazilian Ministry of Health, 2017c).

Prior to this, the Brazilian Academy of Neurology published consensus papers regarding the diagnosis and treatment of Alzheimer’s disease, such as the “recommendations for diagnosing Alzheimer’s disease in Brazil”, developed in 2005, and the “recommendations in Alzheimer” developed in 2011.

References:

Brazilian Ministry of Health. (2017c). PCDT Alzheimer. Brazilian Ministry of Health.

The clinical practice guideline was developed by Indonesia’s Neurologist Association (PERDOSSI) in 2015 (PERDOSSI, 2015).

References:

PERDOSSI. (2015). Panduan Praktik Klinik: Diagnosis dan Penatalaksanaan Demensia. PERDOSSI.

The clinical practice guides are developed mainly in the Ministry of Health, through the National Centre of Technological Excellence in Health (CENETEC). Their updating depends on the identification and evaluation of new evidence, the opinion of experts, as well as the opinion of the team that developed the guide, the perception of users, and the analysis of the context. As there is no defined time to update it, it will rather depend on these points, as well as on the resources, the availability of time, the methodology used, as well as the collaboration of the institutions involved (Secretaría de Salud, 2015a).

References:

Secretaría de Salud. (2015a). Metodología para la integración de Guías de Práctica Clínica en el Sistema Nacional de Salud.

The private sector guidelines discussed above were developed by the South African Society of Psychiatrists (SASOP) and published in 2013.